BTL Industries recently launched Emsculpt NEO, a new body sculpting and contouring device that can help clients in Miami, Florida, reduce fat and build more muscle.
BTL Industries, a privately-owned developer and manufacturer of medical and aesthetic equipment, announced the launch of Emsculpt NEO, a non-invasive body sculpting and contouring device, for clients in Miami, Florida. This new technology aids fat reduction and muscle growth in a fast and safe manner.
More information can be found at https://www.EmsculptNeo.com
The newly launched Emsculpt NEO device at BTL Industries aims to help those who wish to become more fit and achieve their body goals without any invasive procedures.
When a healthier lifestyle and regular exercise fail to give people the body they dream of, they may think that cosmetic surgery is their only option. Fortunately, body contouring is a non-invasive, effective alternative.
Emsculpt NEO is a non-invasive body sculpting and contouring device that promotes permanent fat cell destruction and rapid muscle building results. This device can reduce fat through neuromuscular stimulation, radiofrequency induced lipolysis and increase of the blood flow.
According to clinical studies, those using Emsculpt NEO showed on average a 30% reduction in subcutaneous fat and an increase in muscle volume by 25%. The radiofrequency heating damages the fat cells and slowly removes them from the body, while the extreme stress forces the muscle to adapt and increase muscle fibers and cells.
As Emsculpt NEO has an effect on multiple tissues, the ideal candidate is anyone up to BMI 35. In addition, this device is particularly suitable for those seeking improvement in abdominal appearance, reduction in abdominal circumference or strengthening of buttocks, arms, and calves.
Unlike other body contouring devices, Emsculpt NEO does not need any post or pre-preparations. Users can follow their regular lifestyle after each treatment. The usual protocol is four 30 minutes treatments, separated by 5-10 days.
Emsculpt NEO is FDA cleared for non-invasive lipolysis of the abdomen in patients up to BMI 35. It has also been clinically tested for safety and efficacy through seven clinical studies.
Interested parties can find more by visiting the above-mentioned website.